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Though angioplasty is an established technique for the management of coronary artery disease, there is still controversy about whether it needs on site surgical cover.
The aims of angioplasty and coronary artery bypass surgery in the management of coronary disease are similar, namely to relieve symptoms and in certain groups to improve prognosis, at the lowest risk and morbidity. Because Clearly defined treatment strategies should be developed to prevent or limit myocardial damage once vessel occlusion occurs and there is evidence of myocardial ischaemia. Prompt action is required and the best solution is one achieved immediately by the angioplasty operator-but such attempts are successful in only about 50% of patients and are still associated with a considerable risk of myocardial infarction. More extended use of techniques such as autoperfusion dilatation catheters, stents, laser welding, or arthrectomy devices3 might reduce the need for emergency surgery, but they remain experimental. For patients who are haemodynamically unstable, the use of an intra-aortic balloon pump or percutaneous cardiopulmonary bypass may help to stabilise their condition but should not delay surgical intervention.
Given that surgery is important in the mangement of complications of angioplasty, how close should the operating theatre be to the catheterisation laboratory? It is important to plan for the worst outcome-which is cardiac arrest requiring continuing cardiopulmonary resuscitation. Once vessel occlusion and myocardial ischaemia have occurred and it is clear that further angioplasty techniques have failed, most patients should be transferred to the operating theatre as soon as possible. The effect of the length of the interval from occlusion to surgical revascularisation on subsequent infarction is not clear, largely because it is a non-homogeneous population; however, in large series rates of myocardial infarction in patients requiring emergency surgery varied from 11%,0 to 46% ." Furthermore, the extent of the infarction as well as its occurrence is important and the evidence of the effects of time to reperfusion from studies of thrombolysis indicates the need for rapid intervention.
In a series of 4142 patients in Eindhoven of whom 155 required emergency surgery, five were taken to theatre in cardiac arrest and 19 in cardiogenic shock and were revascularised Parker in a median time of 103 minutes and the remaining patients in a median time of 135 minutes.5 Despite this rapid response time, 4000 of both groups sustained a myocardial infarction. After a careful analysis the Eindhoven workers concluded that the complications of angioplasty remain unpredictable and they recommended continuing surgical cover.
Richardson et al reported on a selected series of 540 angioplasties from Belfast in which 12 patients required urgent surgery and were transferred 2-4 km to another hospital. The mean time to revascularisation was 268 minutes, similar to the time achieved in the receiving hospital.6 Such intervals are twice as long as in the Eindhoven study and most would view them as being unacceptably long. No information was given on the myocardial infarction rate in the surgical patients and in those who developed vessel occlusion but did not undergo surgery. The absence of these data seriously compromises the value of this study.
Prompt revascularisation can best be achieved in hospitals in which there are at least two operating theatres devoted entirely to cardiac surgery. Then emergencies can be handled quickly without seriously interrupting planned operations.
The earlier the patient reaches the theatre the greater the chance that the surgeon will use the internal mammary artery, which in the territory of the anterior descending coronary artery gives a better long term outcome.
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